The impact of the obesity epidemic and the mammography screening program, which preferentially finds slow-growing estrogen receptor (ER)-positive tumors, may be blamed for the rise in ER-positive breast cancer, according to the data that are currently available in several different nations [5]. Here, ESR1 is linked to obesity due to melanocortin 4 receptor deficiency.